🇺🇸 ABS in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 12

Most-reported reactions

1. Endophthalmitis — 2 reports (16.67%)
2. Toxic Anterior Segment Syndrome — 2 reports (16.67%)
3. Coagulopathy — 1 report (8.33%)
4. Conversion Disorder — 1 report (8.33%)
5. Ecchymosis — 1 report (8.33%)
6. Fungal Infection — 1 report (8.33%)
7. Hyponatraemia — 1 report (8.33%)
8. Injection Site Mass — 1 report (8.33%)
9. Injection Site Pain — 1 report (8.33%)
10. Injection Site Swelling — 1 report (8.33%)

Source database →

Frequently asked questions

Is ABS approved in United States?

ABS does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ABS in United States?

Teva Branded Pharmaceutical Products R&D, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.